CytoTronics
PrivateLast Round
Seed
Sep 5, 2024
Total Funding Raised
$22.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CytoTronics is a biotechnology company that develops semiconductor-based systems for studying cell biology, enabling researchers to visualize live cell function at scale and obtain real-time data on cell behavior to explore complex biological processes in greater detail.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Semiconductors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoTronics Comparables
Compare CytoTronics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 3Brain AG | 83% | |
| MaxWell Biosystems | 81% | |
| Axion BioSystems | 80% |
CytoTronics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2024 | ||||
| Seed | Apr 28, 2022 |
CytoTronics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Star | Seed |
| LYFE Capital | Seed |
| BoxOne Ventures | Seed |
| Anzu Partners | Seed |
| Draper Associates | Seed |
| RIT Venture Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors grew 181% MoM, reaching 3.2K.
- Jan 26, 2026
Acquired high-throughput, high-density CMOS MEA technology assets from Axion BioSystems.
CytoTronics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CytoTronics's valuation, stock price, and market status.
Is CytoTronics a public or private company?
CytoTronics is a private company.
What is the current stock price of CytoTronics?
CytoTronics is a private company with no public stock price. No recent secondary market data is available.
How much is CytoTronics worth (valuation)?
Valuation information for CytoTronics is not publicly available.
Can I buy CytoTronics stock?
CytoTronics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CytoTronics's last funding round?
CytoTronics's most recent funding round was Seed on September 5, 2024.
Who are the main investors in CytoTronics?
Key investors in CytoTronics include LYFE Capital, Anzu Partners.
Will CytoTronics IPO soon?
No public IPO plans have been announced for CytoTronics.
How can I track CytoTronics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CytoTronics's secondary market activity and sign up for updates.